SEC Form 4 · accession 0000899243-18-018764
Larimar Therapeutics, Inc. · LRMR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Thomas E. Hughes
Officer — See Remarks · Director
Period of report
Jun 28, 2018
Accepted (ET)
Jun 29, 2018 · 7:01 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001374690
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 28, 2018 | S | 32,000 | $10.00 | D | 125,247 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
Remarks
President and Chief Scientific Officer